On June 30, 2024, Omotesando Helene Clinic received the ESQR (European Society for Quality Research) 2024 Quality Achievements Awards, a Swiss-based European Society for Quality Research.
Official website: https://esqr.org/
Omotesando Helene Clinic has dramatically improved the quality of its medical services by incorporating the latest medical technology and innovative approaches to providing patient-centered care. In particular, in stem cell treatment and stem cell culture, we achieve outstanding therapeutic effects by using cutting-edge technology and strict quality control. The clinic's medical team increases patient satisfaction and builds trust through careful counseling and advanced medical techniques for each patient.
Furthermore, with the aim of providing sustainable medical services, we are also focusing on efforts to strengthen environmentally friendly operations and collaboration with local communities. Through these efforts, Omotesando Helene Clinic has established itself as a quality leader in the medical industry.
This award recognizes the efforts and dedication of all the staff at Omotesando Helen Clinic, and is the result of recognition for the high quality of medical services provided by the clinic and our efforts to continuously improve it. Masu. Omotesando Helene Clinic will continue to strive to improve quality and patient satisfaction, and achieve further evolution.
Past Healthcare Company ESQR Awards
・Janssen Pharma (2023)
・MSD Merck&Co (2019)
Awards for Japanese companies and hospitals
・Kyushu University Hospital (2023)
・Shonan Kamakura Hospital (2023)
・JCR Pharma (2023)
・Takeda Pharmaceutical (2017)
・St. Luke's Hospital (2016)
